Submit Manuscript  

Article Details

Recombinant Antibodies in Cancer Therapy

[ Vol. 7 , Issue. 2 ]


M. S. Nayeem and Rizwan H. Khan   Pages 165 - 170 ( 6 )


The application of recombinant immunotoxin and radioimmunoconjugate in Cancer therapy has revived the "magic bullet" concept predicted a century ago. Many of the recombinant antibodies have received FDA approval for various indication of cancer in recent years and numerous others are in clinical trials.


Cancer therapy, recombinant immunotoxins, radioimmunoconjugates, engineered antibody, recombinant antibody


Interdisciplinary BiotechnologyUnit, Aligarh Muslim University, Aligarh-202002, India.

Read Full-Text article